ARCHIVES

Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA

This article is from The Cancer Letter archive.

Vol. 23 No. 18 | May 9, 1997

Download PDF Visit The Full Archive

Related Articles

NIH review finds 44 scientists violated ethics rules on industry consulting, House committee chairman says.

July 15, 2005

Efaproxyn Improved Survival Of Patients With Brain Mets

October 29, 2004

Afinitor Extends PFS In Women With EGFR-2 Positive Disease

June 28, 2013

Racial Disparities Persist In Diagnosis Of Advanced Breast Cancer, Colon Cancer

February 26, 2010

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

July 27, 2007

Duke Picks Lyerly To Direct Cancer Center

May 2, 2003